Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the acquisition and launch1 of Acetylcysteine Injection, 6 gm/30 mL ...

Glenmark Pharmaceuticals Inc. USA has acquired and launched Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose ...

Glenmark’s Acetylcysteine Injection (DEL) is approved based on the safety and efficacy derived from the reference drug ...

Glenmark Pharmaceuticals has launched injection Acetylcysteine in the US after acquiring its abbreviated new drug application ...

Glenmark Pharmaceuticals added 1.06% to Rs 1292.35 after the US-based subsidiary, Glenmark Pharmaceuticals Inc., USA announced the acquisition and launched of Acetylcysteine Injection, single-dose ...

Glenmark Pharmaceuticals Ltd on Monday said it has  acquired generic version of Acetylcysteine injection from Aspen Pharma ...

This new product will be available in the strength of 6 gm/30 mL (200 mg/mL) single-dose vials in the US market, marking an ...

(RTTNews) - Glenmark Pharmaceuticals Inc., USA announces the acquisition and launch of Acetylcysteine Injection, 6 gm/30 mL Single-Dose Vials. The company acquired the ANDA for Acetylcysteine ...

Glenmark Pharma acquires and launches acetylcysteine injection, 6 gm/30 mL (200 mg/mL) single-dose vials: Our Bureau, Mumbai Monday, March 3, 2025, 12:15 Hrs [IST] Glenmark Pharma ...

Glenmark Pharmaceuticals Inc., USA announced today the acquisition and launch of Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose Vials in the US market. The shares of Glenmark ...